PeterAOryMD

Radiology • Tacoma, WA

Bone Imaging/Musculoskeletal, Neuroradiology

iRad Medical Imaging

Join to view full profile

Dr. Ory is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Ory's full profile

Already have an account?

Office
1304 Fawcett Ave
Tacoma, WA 98402
Phone+1 206-248-9729

Fax+1 206-694-2566
Is this information wrong?

Education & Training

University of WashingtonFellowship, Neuroradiology, 1996 - 1997
University of WashingtonResidency, Radiology-Diagnostic, 1992 - 1996
University of California (San Francisco)Fellowship, Rheumatology, 1986 - 1988
University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1982 - 1986
Baylor College of MedicineClass of 1981

Certifications & Licensure

CA State Medical License 1987 - Present
WA State Medical License 1990 - 2024
OR State Medical License 2015 - 2021
TX State Medical License 1982 - 1987
WI State Medical License 1983 - 1987
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology
American Board of Radiology Diagnostic Radiology

Awards, Honors, & Recognition

Top Doc, Seattle Seattle Met Magazine, 2011-2012
Fellow of the Year University of Washington, Radiology, 1997

Publications & Presentations

PubMed

196 citations
Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)
P. J. Mease, P Ory, John T. Sharp, Christopher T. Ritchlin, F. Van den Bosch, F Wellborne, C. Birbara, Glen T D Thomson, Renee J. Perdok, John R. Medich, Robert L. Won...> ;Annals of the Rheumatic Diseases. 2009 May 1
407 citations
Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blin...
Stanley Cohen, Robin K. Dore, Nancy E Lane, Peter A. Ory, Charles G. Peterfy, John T. Sharp, Désirée Van Der Heijde, L. Zhou, Wayne Tsuji, Richard Newmark> ;Arthritis and Rheumatism. 2008 May 1
214 citations
Adalimumab for long‐term treatment of psoriatic arthritis: Forty‐eight week data from the adalimumab effectiveness in psoriatic arthritis trial
Dafna D. Gladman, Philip J. Mease, Christopher T. Ritchlin, Ernest Choy, John T. Sharp, Peter A. Ory, Renee J. Perdok, Eric H. Sasso> ;Arthritis and Rheumatism. 2007 Feb 1
673 citations
Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double‐blind, randomized, placebo‐controlled trial
Philip J. Mease, Dafna D. Gladman, Christopher T. Ritchlin, Eric Ruderman, Serge Steinfeld, Ernest Choy, John T. Sharp, Peter A. Ory, Renee J. Perdok, M A Weinberg> ;Arthritis and Rheumatism. 2005 Oct 1
15 citations
Radiography in the assessment of musculoskeletal conditions.
P Ory> ;Best Practice & Research. Clinical Rheumatology. 2003 Jun 1
52 citations
Human Synovial Mast Cell Involvement in Rheumatoid Arthritis and Osteoarthritis. Relationship to Disease Type, Clinical Activity, and Antirheumatic Therapy
Alan J. Bridges, Daniel G. Malone, Judy Jicinsky, Marcus Y. Chen, Peter A. Ory, William D. Engber, Frank M. Graziano> ;Arthritis and Rheumatism. 1991 Oct 7
High-resolution inter-ictal SPET and phased-array MRI in partial epilepsy: an imaging comparison with video/EEG and outcome correlation.
Lewis, D. H., Ory, P., Holmes, M. D., Wilensky, A. J., Cohen, W. A., Schneider, J., Ojemann, L. M., Ojemann, G. A.> ;Nucl Med Commun. 1998 Mar
90 citations
Psoriatic arthritis and imaging.
P Ory, Dafna D. Gladman, P. J. Mease> ;Annals of the Rheumatic Diseases. 2005 Mar 1
Interpreting radiographic data in rheumatoid arthritis.
Ory, P. A.> ;Ann Rheum Dis. 2003 Jul
37 citations
Effect of adalimumab on joint disease features of patients with psoriatic arthritis detected by Magnetic Resonance Imaging
Allen P Anandarajah, P Ory, D Salonen, Changyong Feng, Robert L. Wong, Christopher T. Ritchlin> ;Annals of the Rheumatic Diseases. 2010 Jan 1
397 citations
Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept
D. van der Heijde, Robert Landewé, S. Einstein, P Ory, D Vosse, L. Ni, Shao Lee Lin, Wayne Tsuji, John C. Davis> ;Arthritis and Rheumatism. 2008 May 1
84 citations
Denosumab‐mediated increase in hand bone mineral density associated with decreased progression of bone erosion in rheumatoid arthritis patients
A. Deodhar, R. K. Dore, D. Mandel, J. Schechtman, W. Shergy, R. Trapp, P Ory, Charles Peterfy, T. Fuerst, H. Wang, L. Zhou, Wayne Tsuji, Richard Newmark> ;Arthritis Care & Research. 2010 Apr 1
158 citations
Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept.
Philip J. Mease, Alan Kivitz, Francis X. Burch, Evan L. Siegel, Stanley B. Cohen, P Ory, David Salonen, Joel Rubenstein, John T. Sharp, Meleana Dunn, Wayne Tsuji> ;The Journal of Rheumatology. 2006 Apr 1
665 citations
Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression
Philip J. Mease, Alan Kivitz, Francis X. Burch, Evan L. Siegel, Stanley B. Cohen, P Ory, David Salonen, Joel Rubenstein, John T. Sharp, Wayne Tsuji> ;Arthritis and Rheumatism. 2004 Jul 1
43 citations
Denosumab prevents metacarpal shaft cortical bone loss in patients with erosive rheumatoid arthritis.
John T. Sharp, Wayne Tsuji, P Ory, Cristina Harper-Barek, H. Wang, Richard Newmark> ;Arthritis Care & Research. 2010 Apr 1
Join now to see all